Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
CPT® Code 96445 refers to the administration of chemotherapy directly into the peritoneal cavity, which is the space within the abdomen that houses various organs. This procedure is significant in the treatment of certain cancers, as it allows for localized delivery of chemotherapy agents, potentially increasing the effectiveness of the treatment while minimizing systemic exposure. The term "peritoneocentesis" included in the description indicates that the procedure requires the insertion of a needle through the abdominal wall to access the peritoneal cavity. This step is crucial as it facilitates the administration of the chemotherapy directly into the targeted area, ensuring that the medication can act on cancer cells present in the abdominal cavity. The procedure is typically performed in a clinical setting by a qualified healthcare professional, and it is essential for medical coders and billers to understand the specifics of this code to ensure accurate billing and compliance with coding guidelines.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 96445 is indicated for patients who require localized chemotherapy treatment for specific abdominal cancers. The following conditions may warrant the use of this procedure:
The procedure for CPT® Code 96445 involves several critical steps to ensure safe and effective chemotherapy administration into the peritoneal cavity. Each step is essential for the successful execution of the procedure:
Post-procedure care for patients who have undergone chemotherapy administration into the peritoneal cavity is essential for ensuring a safe recovery. Patients are typically advised to rest and may be monitored for a short period in a clinical setting to observe for any immediate side effects or complications. It is important for patients to report any unusual symptoms, such as increased abdominal pain, fever, or signs of infection, to their healthcare provider promptly. Follow-up appointments are usually scheduled to assess the effectiveness of the treatment and to plan any additional therapies that may be necessary. Patients may also receive guidance on managing side effects associated with chemotherapy, including nausea or fatigue, as part of their comprehensive care plan.
| Short Descr | CHEMOTHERAPY, INTRACAVITARY | Medium Descr | CHEMOTX ADMN PRTL CAVITY REQ&W/PRITONEOCNTS | Long Descr | Chemotherapy administration into peritoneal cavity, requiring and including peritoneocentesis | Status Code | Active Code | Global Days | 000 - Endoscopic or Minor Procedure | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Significant Procedure, Not Discounted When Multiple | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | P7B - Oncology - other | MUE | Not applicable/unspecified. | CCS Clinical Classification | 224 - Cancer chemotherapy |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Deleted | Code deleted, to report use 96446 |
| 1990-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.